The organisms that make up your microbiome impact how your body processes food and your overall health. Here's how you can keep your microbiome healthy.
Dr. Orville Kolterman
Orville Kolterman is the Chief Medical Officer at Pendulum. Dr. Kolterman received his BA degree from the University of Kansas followed by a MD degree from Stanford University and postgraduate training in Endocrinology and Metabolism. Following stints on the faculty at the University of Colorado and University of California, San Diego, he embarked upon a parallel career in drug development at Amylin Pharmaceuticals, Inc. Prior to his appointment as Senior Vice President & Chief Medical Officer, Dr. Kolterman held leadership roles in the regulatory, research, development, clinical and medical affairs departments, many of which were officer-level positions. During his 20 year tenure at Amylin, Dr. Kolterman led teams that developed four novel, first in class, drugs currently used by patients with both type 1 and type 2 diabetes. One of the drugs has an orphan indication for the treatment of lipodystrophy. Amylin was acquired by Bristol Myers Squibb in 2012.